Analgesia Clinical Trial
Official title:
Ultrasound Guided : Retrolaminar Block Versus Thoracic Epidural Analgesia for Pain Control Following Laparoscopic Cholecystectomy
NCT number | NCT04835415 |
Other study ID # | 6777 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 10, 2021 |
Est. completion date | December 1, 2021 |
Verified date | January 2022 |
Source | Zagazig University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate analgesic effect of ultrasound-guided retrolaminar block vs ultrasound-guided thoracic epidural analgesia in pain control following laparoscopic cholecystectomy.
Status | Completed |
Enrollment | 52 |
Est. completion date | December 1, 2021 |
Est. primary completion date | November 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 45 Years |
Eligibility | Inclusion Criteria: - Written informed consent from the patient. - Age: 21-45 years old. - Sex: both sex (males and females). - Physical status: ASA 1& II. - BMI = (25-35 kg/m2). - Type of operation: elective laparoscopic cholecystectomy Exclusion Criteria: - Altered mental state. - Patients with known history of allergy to study drugs. - Advanced hepatic, renal, cardiovascular, and respiratory diseases. - Patients with chronic pain. - Patients receiving anticoagulants. - Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy, or septic focus at site of injection. |
Country | Name | City | State |
---|---|---|---|
Egypt | faculty of medicine, Zagazig university | Zagazig |
Lead Sponsor | Collaborator |
---|---|
Zagazig University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | 30 minutes postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 1 hour postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 2 hours postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 4 hours postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 6 hours postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 8 hours postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 10 hours postoperative | |
Primary | Pain intensity at rest and at cough using Numerical Rating Scales (NRS) | measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) | at 12 hours postoperative | |
Secondary | Time to first call of rescue analgesia | start from retrolaminar or epidural injection of the drug to the time of first call of naluphine | within 12 hours postoperative | |
Secondary | Total analgesic (Naluphine) consumption | Total consumption of rescue analgesia(Naluphine) post operative | within 12 hours postoperative | |
Secondary | The number of participant with complications of the techinque (dural puncture , nerve injury, spinal injection, epidural haematoma, pleural puncture) | The numer of participant with complications of the techinque (dural puncture , nerve injury, spinal injection, epidural haematoma, pleural puncture) | within 24 hours postoperative | |
Secondary | Patient satisfaction is recorded at the end of 24 hours postoperative | using 5-point Likert-like verbal rating scale by asking the patient about "how he/she evaluated their experience with the analgesic management after the surgery?"5=very satisfied, 4=satisfied, 3= neutral, 2= dissatisfied and 1= very dissatisfied". | 24 hours postoperative | |
Secondary | The number of participant with nausea, vomiting, hypotension and bradycardia. | the number of participant with nausea (sensation of being about to vomit), vomiting (the expelling of the food content from the stomach through mouth, it will be treated by 4 mg ondansetron), hypotension (if MAP decreases more than 20% of basal reading it will be treated by 12 mg ephedrine) and bradycardia (if HR less than 50 beats/min it will be treated by 0.5 mg atropine). | 24 hours postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05534230 -
Dexmedetomidine for Pain Reduction in CABG
|
N/A | |
Recruiting |
NCT06275698 -
HONEY for the Treatment of POst-Tonsillectomy Pain
|
N/A | |
Recruiting |
NCT04436224 -
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
|
Phase 4 | |
Not yet recruiting |
NCT04548323 -
Hypoalgesic Effects of Walking and Running Imagined
|
||
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Completed |
NCT04394481 -
Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery
|
Phase 4 | |
Completed |
NCT04690647 -
The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.
|
N/A | |
Completed |
NCT05034601 -
ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure
|
N/A | |
Completed |
NCT03740815 -
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
|
N/A | |
Recruiting |
NCT05454202 -
Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
|
||
Recruiting |
NCT04554186 -
Serratus Anterior Plane Block Versus Thoracic Paravertebral Block.
|
N/A | |
Not yet recruiting |
NCT06393777 -
Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion
|
N/A | |
Suspended |
NCT04860635 -
Safety of F14 Following Total Knee Replacement
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04519463 -
The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing
|
Early Phase 1 | |
Completed |
NCT02916342 -
Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks
|
Phase 4 | |
Completed |
NCT03206554 -
Local Infiltration Analgesia in Total Knee Arthroplasty
|
Phase 2 | |
Not yet recruiting |
NCT02549118 -
Tenoxicam for Intrapartum Analgesia
|
Phase 2 | |
Not yet recruiting |
NCT02190760 -
Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block.
|
N/A | |
Completed |
NCT01789606 -
Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet
|
Phase 3 | |
Completed |
NCT01299584 -
ULTIVA Post Marketing Surveillance
|
N/A |